A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition - ScienceDirect

Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking

Mucosal plasma cells are required to protect the upper airway and

A Replication-Competent Vesicular Stomatitis Virus for Studies of

A single dose of replication-competent VSV-vectored vaccine

Nanoluciferase complementation-based bioreporter reveals the

Multiple SARS-CoV-2 variants escape neutralization by vaccine

Cell culture systems for isolation of SARS-CoV-2 clinical isolates

Studying Virus Replication with Fluorescence Microscopy, people playground steamunlocked

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication

A Replication-Competent Vesicular Stomatitis Virus for Studies of